These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28947471)

  • 21. Successful treatment of extensively drug-resistant Acinetobacter baumannii peritoneal dialysis peritonitis with intraperitoneal polymyxin B and ampicillin-sulbactam.
    Fitzpatrick MA; Esterly JS; Postelnick MJ; Sutton SH
    Ann Pharmacother; 2012; 46(7-8):e17. PubMed ID: 22811349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii.
    Chung JH; Bhat A; Kim CJ; Yong D; Ryu CM
    Sci Rep; 2016 Jun; 6():28168. PubMed ID: 27306928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-Genome Analysis of an Extensively Drug-Resistant Acinetobacter baumannii Strain XDR-BJ83: Insights into the Mechanisms of Resistance of an ST368 Strain from a Tertiary Care Hospital in China.
    Zhang YY; Liang ZX; Li CS; Chang Y; Ma XQ; Yu L; Chen LA
    Microb Drug Resist; 2018 Nov; 24(9):1259-1270. PubMed ID: 29489445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
    Durante-Mangoni E; Signoriello G; Andini R; Mattei A; De Cristoforo M; Murino P; Bassetti M; Malacarne P; Petrosillo N; Galdieri N; Mocavero P; Corcione A; Viscoli C; Zarrilli R; Gallo C; Utili R
    Clin Infect Dis; 2013 Aug; 57(3):349-58. PubMed ID: 23616495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stable polymyxin B susceptibility among carbapenem-resistant Acinetobacter baumannii: for how long?
    Reus Rodrigues Perez L; Luís Barth A
    J Chemother; 2017 Feb; 29(1):60-61. PubMed ID: 26300348
    [No Abstract]   [Full Text] [Related]  

  • 28. Nosocomial Infections Caused by Acinetobacter baumannii: Are We Losing the Battle?
    Protic D; Pejovic A; Andjelkovic D; Djukanovic N; Savic D; Piperac P; Markovic Denic L; Zdravkovic M; Todorovic Z
    Surg Infect (Larchmt); 2016 Apr; 17(2):236-42. PubMed ID: 26885722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial commentary: rifampicin plus colistin in the era of extensively drug-resistant Acinetobacter baumannii infections.
    Gauthier TP
    Clin Infect Dis; 2013 Aug; 57(3):359-61. PubMed ID: 23616496
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model.
    Zhou J; Ledesma KR; Chang KT; Abodakpi H; Gao S; Tam VH
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissemination of class I integron in Acinetobacter baumliannii isolated from ventilator-associated pneumonia patients and their environment.
    Sirichot S; Diraphat P; Utrarachkij F; Tribuddharat C; Siripanichgon K
    Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1284-92. PubMed ID: 20578463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii.
    Qin Y; Zhang J; Wu L; Zhang D; Fu L; Xue X
    Int J Clin Pharmacol Ther; 2018 Mar; 56(3):120-129. PubMed ID: 29319497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges to conducting a clinical trial of combination therapy of colistin and rifampicin for extensively drug-resistant Acinetobacter baumannii.
    Huang DB; Pastagia M; Chiang T
    Clin Infect Dis; 2014 Jan; 58(1):141-2. PubMed ID: 24081682
    [No Abstract]   [Full Text] [Related]  

  • 35. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
    Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N
    New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients].
    Pérez-Pedrero MJ; Sánchez-Casado M; Rodríguez-Villar S
    Med Intensiva; 2011 May; 35(4):226-31. PubMed ID: 21396739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
    Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A
    J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
    Fan B; Guan J; Wang X; Cong Y
    PLoS One; 2016; 11(6):e0157757. PubMed ID: 27315107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
    Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.